artificial intelligence β’ pathology β’ digital pathology β’ oncology β’ immuno-oncology
501 - 1000 employees
Founded 2016
π€ Artificial Intelligence
βοΈ Healthcare Insurance
𧬠Biotechnology
π° $165M Series C on 2021-05
October 17
artificial intelligence β’ pathology β’ digital pathology β’ oncology β’ immuno-oncology
501 - 1000 employees
Founded 2016
π€ Artificial Intelligence
βοΈ Healthcare Insurance
𧬠Biotechnology
π° $165M Series C on 2021-05
β’ PathAI is seeking an experienced Principal Regulatory Affairs Specialist to support regulatory strategies and ensure the success of diagnostic products globally. β’ This role involves preparing global product submissions, including PMA, 510(k), UKCA, and IVDR filings. β’ Work cross-functionally with internal stakeholders, providing regulatory guidance throughout the product development lifecycle.
β’ 5+ years of experience in regulatory affairs, focusing on diagnostic devices and proven experience with FDA and EMA Dx submissions (510(k), PMA, IVDR). β’ Expertise in regulatory submissions for in vitro diagnostic devices (IVD), particularly in AI-driven technologies, pathology, and SaMD (Software as a Medical Device). β’ Demonstrated hands-on experience in leading regulatory filings and bringing products to market globally, emphasizing the US and EU markets. β’ Experience with US Class III and EU IVDR Class C (high-risk) medical device development. Knowledge of global regulatory standards, including FDA QSR, ISO 13485, IVDR, and ISO 14971.
Apply NowOctober 17
Support regulatory team at Dexcom by reviewing and approving promotional materials.
πΊπΈ United States β Remote
π΅ $111.1k - $185.1k / year
β° Full Time
π΄ Lead
π Compliance
π¦ H1B Visa Sponsor
October 3
501 - 1000
Director ensuring GCP compliance in Americas for BeiGene's oncology treatments.
September 24
Manage teams for IRS Form 5500 filings at Transamerica.
πΊπΈ United States β Remote
π΅ $105k - $125k / year
β° Full Time
π΄ Lead
π Compliance
π¦ H1B Visa Sponsor
September 24
Lead compliance program at Conversant Group, a security consulting company.
September 20
Lead regulatory strategy for Orca Bioβs next-generation cell therapies.